Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC

NCT02018757 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG: TACE containing As2O3
DRUG: TACE containing placebo

Sponsor

First Hospital of China Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]